Rocket Lab TodayRKLBRocket Lab$85.96 +5.27 (+6.53%) As of 12:20 PM Eastern This is a fair market value price provided by Massive. Learn more.52-Week Range$33.73▼$151.00Price Target$102.76Add to WatchlistRocket Lab NASDAQ: RKLB has had a brutal few weeks.
ABT falls 29.4% YTD as respiratory testing weakness, China uncertainty and acquisition dilution pressure results and outlook.
I keep hitting the buy button on SoFi Technologies (NASDAQ:SOFI | SOFI Price Prediction), and the Fed-driven tech sell-off this month has only made my finger heavier.
Sociedad Química y Minera de Chile posted mixed Q1 results, with revenues beating estimates, while revenues were a sizable miss. The bigger story is the dramatic Y-O-Y rise in revenues and earnings, with long-term fundamentals suggesting that positive financial momentum is likely to continue. I initiated a stock position in SQM, with an intent to buy more on further dips, as a broader strategy to build a core lithium position in my portfolio.
Starz Entertainment remains a compelling "Buy," with strong tailwinds and an attractive valuation despite doubling YTD. Exiting the unprofitable Universal Pay Two deal accelerates STRZ's path to a 20% OIBDA margin by late 2027. Byron Allen's 11% stake and takeover interest provide a potential catalyst, but STRZ is undervalued even without a deal.
Virtuix NASDAQ: VTIX executives outlined the company's consumer, enterprise and defense strategy during an investor webinar, while also addressing recent volatility in the company's share price.
The SOX continues to follow its projected historical returns and Elliott Wave path, but the advance may be nearing exhaustion, raising the probability of a retracement toward $10,000.
The AI chip maker has a storied relationship with the $200 mark. They haven't always got on.
The increasingly lofty premium Navitas has garnered since announcing the collaboration with Nvidia on 800V HVDCs underscores a valuation that's gone too far, too fast. Just the past week, Navitas Semiconductor stock gained close to 20% overnight on no particular headline—a potential opportunity to cash in before upcoming earnings volatility. Trading at 44x 2027 sales and with limited visibility into a sustained earnings inflection, NVTS stock remains a high-risk, low-reward pick in the market's favored AI infrastructure trade.
Falling egg prices hurt the egg producer's top and bottom lines in the third quarter.
The Fear and Greed Index is worth checking in on at moments like this, when the S&P 500 is on the verge of a correction.
Hannover Re delivered strong FY 2025 results, meeting guidance with net income of EUR 2.64 billion and EPS of EUR 21.90. The combined ratio remains below 90%, reflecting disciplined underwriting and robust performance in both P&C and Life & Health segments. HNR1 proposes a EUR 12.50 dividend per share (55% payout), retaining earnings to support future growth and maintain capital strength.